文献速递糖尿病肥胖与代谢综合征

血浆脂质组谱与糖尿病风险:HIV感染与未感染者的两项前瞻性队列研究

Plasma Lipidomic Profiles and Risk of Diabetes: 2 Prospective Cohorts of HIV-Infected and HIV-Uninfected Individuals.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

在491名HIV感染者和203名HIV未感染者中分析了211种血浆脂质,中位随访12.6年发现166例糖尿病。11种脂质与糖尿病风险独立相关,其中5种降低风险(HR 0.70–0.82),5种升高风险(HR 1.26–1.56),HIV血清状态未改变这些关联,但多数糖尿病相关脂质在HIV感染或ART使用者中升高。

要点

  • 11种血浆脂质与糖尿病风险独立相关,涵盖8个脂质类别/亚类。
  • CE(22:4)、LPC(18:2)、PC(36:4)、PC缩醛磷脂(34:3)、PE(38:2)与糖尿病风险降低相关。
  • DAG(32:0)、LPC(14:0)、PC(38:3)、PE(36:1)、TAG(50:1)与糖尿病风险升高相关。

核心结论

  • 多种血浆脂质与糖尿病发病风险相关,且多数糖尿病相关脂质在ART治疗的HIV感染者中升高。

研究设计与样本

  • 前瞻性队列研究,纳入491名HIV感染者和203名HIV未感染者,年龄35至55岁,来自女性跨机构HIV研究和多中心AIDS队列研究。
  • 基线检测211种血浆脂质,中位随访12.6年,发现166例糖尿病。
  • 采用Cox比例风险模型分析基线脂质与糖尿病发病的关联。

主要发现

  • 11种脂质代表8个脂质类别/亚类的独立信号,与糖尿病风险相关(FDR校正后P<0.05)。
  • CE(22:4)、LPC(18:2)、PC(36:4)、PC缩醛磷脂(34:3)、PE(38:2)与糖尿病风险降低相关(每SD增量HR=0.70至0.82)。
  • DAG(32:0)、LPC(14:0)、PC(38:3)、PE(36:1)、TAG(50:1)与糖尿病风险升高相关(每SD增量HR=1.26至1.56)。
  • HIV血清状态未修饰任何脂质-糖尿病关联。
  • 多数糖尿病相关脂质与HIV感染和/或ART使用正相关,包括3种糖尿病风险降低脂质(CE[22:4]、LPC[18:2]、PE[38:2])和全部5种糖尿病风险升高脂质。

临床怎么用

  • 在HIV感染者中监测特定血浆脂质物种可能有助于评估糖尿病风险。
  • ART治疗者中多种糖尿病相关脂质升高,提示脂质在ART与糖尿病关联中作用复杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Antiretroviral therapy (ART) use is associated with disrupted lipid and glucose metabolism in people with HIV infection. We aimed to identify plasma lipid species associated with risk of diabetes in the context of HIV infection. RESEARCH DESIGN AND METHODS: We profiled 211 plasma lipid species in 491 HIV-infected and 203 HIV-uninfected participants aged 35 to 55 years from the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. Cox proportional hazards model was used to examine associations between baseline lipid species and incident diabetes (166 diabetes cases were identified during a median follow-up of 12.6 years). RESULTS: We identified 11 lipid species, representing independent signals for 8 lipid classes/subclasses, associated with risk of diabetes (P < 0.05 after FDR correction). After adjustment for multiple covariates, cholesteryl ester (CE) (22:4), lysophosphatidylcholine (LPC) (18:2), phosphatidylcholine (PC) (36:4), phosphatidylcholine plasmalogen (34:3), and phosphatidylethanolamine (PE) (38:2) were associated with decreased risk of diabetes (HRs = 0.70 to 0.82 per SD increment), while diacylglycerol (32:0), LPC (14:0), PC (38:3), PE (36:1), and triacylglycerol (50:1) were associated with increased risk of diabetes (HRs = 1.26 to 1.56 per SD increment). HIV serostatus did not modify any lipid-diabetes associations; however, most of these lipid species were positively associated with HIV and/or ART use, including 3 diabetes-decreased ( CE [22:4], LPC [18:2], PE [38:2]) and all 5 diabetes-increased lipid species. CONCLUSIONS: This study identified multiple plasma lipid species associated with incident diabetes. Regardless of the directions of their associations with diabetes, most diabetes-associated lipid species were elevated in ART-treated people with HIV infection. This suggests a complex role of lipids in the link between ART and diabetes in HIV infection.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhang E, Chai JC, Deik AA, et al. Plasma Lipidomic Profiles and Risk of Diabetes: 2 Prospective Cohorts of HIV-Infected and HIV-Uninfected Individuals. J Clin Endocrinol Metab. 2021. PMID: 33420793. doi:10.1210/clinem/dgab011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。